Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate became rich by selling 'sick' pharma companies

At just 39, Vivek Ramaswamy, a self-made billionaire and co-director of Trump's Department of Government Efficiency (DOGE), is a big advocate of a unified America through the power of capitalism. Known for his self-made wealth and outspoken support for capitalism, Ramaswamy’s financial success originates from his biotech company, Roivant Sciences, and diverse investments across technology, cryptocurrency, and asset management. Ramaswamy, a graduate of Harvard and Yale Law School, is also a big proponent of economic philosophy, which he terms as “excellence capitalism”. Born in the US to Indian immigrant parents, Ramaswamy rose to political prominence in 2023 when he declared his candidacy for the Republican Party nomination.

Vivek Ramaswamy's Net Worth: Building Wealth Through Biotech

Ramaswamy featured in Forbes' Richest Entrepreneurs Under 40 and also richest 30 under 30 list. As per Forber real time net worth list, the biotech professional has a net worth of over $1 billion. Ramaswamy’s primary source of wealth is Roivant Sciences, a biotech company he founded in 2014. His business strategy centers on acquiring and developing overlooked pharmaceuticals, which are then moved toward commercialization. In 2016, Ramaswamy was instrumental in launching Myovant Sciences, a Roivant subsidiary, in what was the largest biotech initial public offering (IPO) of the year, raising $218 million through a Nasdaq listing.

A pivotal moment for Roivant—and Ramaswamy’s wealth—came in 2020 when Japanese company Sumitomo Dainippon purchased a portfolio of five Roivant drugs and a 10% company stake for $3 billion. This sale provided Ramaswamy with an estimated $176 million in capital gains, significantly expanding his financial standing. In 2021, Roivant’s valuation surged to $7.3 billion following a merger through a Special Purpose Acquisition Company (SPAC), with Ramaswamy’s 7% stake valued at approximately $511 million at that time.

Diversified Investments

Apart from his work in biotech, Ramaswamy diversified his portfolio across various industries. He allocated his earnings into a mix of stocks and bonds, alongside investments in emerging technologies, including cryptocurrency assets like Bitcoin and Ethereum. As per Forbes, Ramaswamy also holds stakes in YouTube competitor Rumble and the crypto payments firm MoonPay. These investments reflect his confidence in digital technology and finance, further boosting his wealth and expanding his business influence.

Entering Politics and Advocating “Excellence Capitalism”

Ramaswamy transitioned from biotech to politics in 2021, publishing Woke, Inc. to critique corporate America's focus on social issues. He later founded Strive Asset Management, an “anti-woke” investment firm valued at approximately $300 million, with backing from notable investors like Peter Thiel and Bill Ackman. Describing his approach as “excellence capitalism,” Ramaswamy advocates for companies to prioritize customer-focused excellence over social or political goals, positioning himself in contrast to the stakeholder capitalism model.

Ramaswamy maintains modest lifestyle

Despite his wealth, Ramaswamy maintains a modest lifestyle, with two Ohio homes collectively valued at $2.5 million. Although he owns stakes in private jets for efficient travel, he emphasizes that his use of private aviation is primarily to “buy time with family.” Ramaswamy’s down-to-earth image resonates with supporters, some of whom feel he brings an uncommon authenticity to the political stage.